Aura Biosciences, Inc.
AURA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501796
No open-market purchases or sales by Aura Biosciences, Inc. insiders were filed in the last 90 days; 146 institutions reported holding it in 13F filings for Q2 2026, worth $677.2M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Aura Biosciences, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 126
- +11 vs. Q4 2025
- Shares held
- 50.9M
- +3.58M (+7.6%) vs. Q4 2025
- Total value
- $340.3M
- +$82.6M (+32.0%) vs. Q4 2025
- New holders
- 23
- 39 more added
- Sold out
- 12
- 41 more reduced
2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AURA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 146 | $677.2M |
| Q1 2026 | 126 | $340.3M |
| Q4 2025 | 117 | $273.8M |
| Q3 2025 | 106 | $319.2M |
| Q2 2025 | 105 | $316.9M |
| Q1 2025 | 94 | $231.5M |
| Q4 2024 | 94 | $324.3M |
| Q3 2024 | 81 | $329.2M |
| Q2 2024 | 75 | $300.4M |
| Q1 2024 | 78 | $307.1M |
| Q4 2023 | 72 | $327.8M |
| Q3 2023 | 64 | $254.4M |
| Q2 2023 | 59 | $334.4M |
| Q1 2023 | 57 | $232.6M |
| Q4 2022 | 49 | $250.0M |
| Q3 2022 | 43 | $295.7M |
| Q2 2022 | 44 | $223.8M |
| Q1 2022 | 34 | $298.8M |
| Q4 2021 | 32 | $220.1M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Aura Biosciences, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Goldman Sachs Group Inc | 178,726 | $1.20M | 0.00% | +38,800+27.7% | Added |
| Morgan Stanley | 224,041 | $1.50M | 0.00% | +5,634+2.6% | Added |
| Caligan Partners LP | 229,864 | $1.54M | 0.11% | +229,864 | New |
| Vanguard Portfolio Management LLC | 391,334 | $2.62M | 0.00% | +391,334 | New |
| Vanguard Fiduciary Trust Co | 397,160 | $2.66M | 0.00% | +397,160 | New |
| Price T Rowe Associates Inc | 415,191 | $2.78M | 0.00% | −27,598−6.2% | Reduced |
| Northern Trust Corp | 430,522 | $2.88M | 0.00% | +17,713+4.3% | Added |
| Regency Capital Management Inc. | 532,495 | $3.56M | 1.59% | −6,089−1.1% | Reduced |
| Balyasny Asset Management LLC | 557,654 | $3.73M | 0.01% | +557,654 | New |
| Dimensional Fund Advisors LP | 558,158 | $3.73M | 0.00% | +40,242+7.8% | Added |
| Acorn Capital Advisors, LLC | 595,744 | $3.99M | 1.13% | 00.0% | Unchanged |
| B Group, Inc. | 597,576 | $4.00M | 2.96% | +25,000+4.4% | Added |
| Levin Capital Strategies, L.P. | 941,400 | $6.30M | 0.48% | −94,186−9.1% | Reduced |
| State Street Corp | 964,670 | $6.45M | 0.00% | +38,136+4.1% | Added |
| Millennium Management LLC | 1,097,627 | $7.34M | 0.01% | +480,289+77.8% | Added |
| Geode Capital Management, LLC | 1,310,862 | $8.77M | 0.00% | +55,412+4.4% | Added |
| Franklin Resources Inc | 2,072,726 | $13.9M | 0.00% | −125,697−5.7% | Reduced |
| Nantahala Capital Management, LLC | 2,117,697 | $14.2M | 0.88% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 2,243,828 | $15.0M | 0.00% | +2,243,828 | New |
| Medicxi Ventures Management (Jersey) Ltd | 3,039,892 | $20.3M | 2.07% | 00.0% | Unchanged |
| BlackRock, Inc. | 3,586,640 | $24.0M | 0.00% | +26,216+0.7% | Added |
| Suvretta Capital Management, LLC | 4,372,884 | $29.3M | 0.79% | 00.0% | Unchanged |
| Long Focus Capital Management, LLC | 4,619,582 | $30.9M | 1.36% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 4,881,125 | $32.7M | 0.05% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 5,100,000 | $34.1M | 0.88% | 00.0% | Unchanged |
| Matrix Capital Management Company, LP | 6,922,870 | $46.3M | 100.00% | 00.0% | Unchanged |
| Decheng Capital LLC | 0 | $0 | 0.00% | −360,483−100.0% | Sold out |
| Resolute Capital Asset Partners LLC | 0 | $0 | 0.00% | −91,006−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −47,431−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −46,371−100.0% | Sold out |
| Harbor Capital Advisors, Inc. | 0 | $0 | 0.00% | −32,977−100.0% | Sold out |
| Opal Capital LLC | 0 | $0 | 0.00% | −22,034−100.0% | Sold out |
| Ethic Inc. | 0 | $0 | 0.00% | −17,539−100.0% | Sold out |
| Mirabella Financial Services LLP | 0 | $0 | 0.00% | −14,109−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −10,830−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −1,380−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −165−100.0% | Sold out |
| Larson Financial Group LLC | 0 | $0 | 0.00% | −95−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Comerica Bank | – | – | – | – | Not filed |